MediciNova MNOV Stock
MediciNova Price Chart
MediciNova MNOV Financial and Trading Overview
| MediciNova stock price | 1.4 USD |
| Previous Close | 1.4 USD |
| Open | 1.4 USD |
| Bid | 0.95 USD x 200 |
| Ask | 1.71 USD x 200 |
| Day's Range | 1.39 - 1.45 USD |
| 52 Week Range | 1.22 - 3.9 USD |
| Volume | 61.65K USD |
| Avg. Volume | 331.99K USD |
| Market Cap | 71.47M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.21 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.25 USD |
MNOV Valuation Measures
| Enterprise Value | 42.31M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.7087379 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 76.37947 |
| Price/Book (mrq) | 1.8428004 |
| Enterprise Value/Revenue | 45.221 |
| Enterprise Value/EBITDA | -3.676 |
Trading Information
MediciNova Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -0.70% |
| S&P500 52-Week Change | 13.32% |
| 52 Week High | 3.9 USD |
| 52 Week Low | 1.22 USD |
| 50-Day Moving Average | 1.78 USD |
| 200-Day Moving Average | 1.5 USD |
MNOV Share Statistics
| Avg. Volume (3 month) | 331.99K USD |
| Avg. Daily Volume (10-Days) | 52.04K USD |
| Shares Outstanding | 51.23M |
| Float | 44.7M |
| Short Ratio | 2.73 |
| % Held by Insiders | 2.83% |
| % Held by Institutions | 24.59% |
| Shares Short | 285.18K |
| Short % of Float | 0.57% |
| Short % of Shares Outstanding | 0.55% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1232.17% |
| Gross Margin | 42.24% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.52% |
| Return on Equity (ttm) | -24.79% |
Income Statement
| Revenue (ttm) | 935.72K USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | 12.40% |
| Gross Profit (ttm) | 395.25K USD |
| EBITDA | -11512367 USD |
| Net Income Avi to Common (ttm) | -10545638 USD |
| Diluted EPS (ttm) | -0.21 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.26M USD |
| Total Cash Per Share (mrq) | 0.57 USD |
| Total Debt (mrq) | 100.54K USD |
| Total Debt/Equity (mrq) | 0.25 USD |
| Current Ratio (mrq) | 8.749 |
| Book Value Per Share (mrq) | 0.757 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9792496 USD |
| Levered Free Cash Flow (ttm) | -6790181 USD |
Profile of MediciNova
| Country | United States |
| State | CA |
| City | La Jolla |
| Address | 4275 Executive Square |
| ZIP | 92037 |
| Phone | 858 373 1500 |
| Website | https://medicinova.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Q&A For MediciNova Stock
What is a current MNOV stock price?
MediciNova MNOV stock price today per share is 1.4 USD.
How to purchase MediciNova stock?
You can buy MNOV shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MediciNova?
The stock symbol or ticker of MediciNova is MNOV.
Which industry does the MediciNova company belong to?
The MediciNova industry is Biotechnology.
How many shares does MediciNova have in circulation?
The max supply of MediciNova shares is 51.23M.
What is MediciNova Price to Earnings Ratio (PE Ratio)?
MediciNova PE Ratio is now.
What was MediciNova earnings per share over the trailing 12 months (TTM)?
MediciNova EPS is -0.21 USD over the trailing 12 months.
Which sector does the MediciNova company belong to?
The MediciNova sector is Healthcare.
MediciNova MNOV included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
|
- | |||||
US Tech Composite
IXIC
US
|
25136.27 USD — |
-0.91
|
7.74B USD — | 24872.41 USD — | 25423.09 USD — | — - | 7.74B USD — |
|
US Tech Global Market Composite
NQGM
US
|
1937.83 USD — |
-1.05
|
— — | 1915.46 USD — | 1955.74 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1368.29 USD — |
-0.34
|
— — | 1358.68 USD — | 1373.65 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31061.46 USD — |
-0.9
|
— — | 30735.41 USD — | 31415.87 USD — | — - | — — |
